Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Pulsed Field Ablation With the PulseMagic™ TrueForce™ Catheter and PulseMagic™ PFA Generator for the Treatment of Paroxysmal Atrial Fibrillation (PFATrueForce)

NCT07720557 is registered in ClinicalTrials.gov with Shanghai MicroPort EP MedTech Co., Ltd. as lead sponsor.

NCT NCT07720557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07720557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Pulsed Field Ablation With the PulseMagic™ TrueForce™ Catheter and PulseMagic™ PFA Generator for the Treatment of Paroxysmal Atrial Fibrillation (PFATrueForce)
Lead sponsor
Shanghai MicroPort EP MedTech Co., Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 10, 2026
Completion date
November 30, 2028
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial arrhythmia, atrial fibrillation (af), drug refractory paroxysmal atrial fibrillation, paroxysmal af